ArticleCancers2022

Targeting MUC1-C Suppresses Chronic Activation of Cytosolic Nucleotide Receptors and STING in Triple-Negative Breast Cancer.

Nami Yamashita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.